ubenimex
antileukemic
candoxatrilat
telinavir
bortezomib
palinavir
sepimostat
lasinavir
ixazomib
thioguanine
vosaroxin
idelalisib
talacotuzumab
aloxistatin
venetoclax
omacetaxine
murinoglobulin
epoxomicin
bestatin
spumigin
ecabet
ponatinib
denagliptin
asciminib
chloraminophene
leukoprotease
danoprevir
clofarabine
protealide
tyrosine kinase inhibitor
cystatin
gemtuzumab ozogamicin
pegaspargase
chelidostatin
folliculin
promyeloleukemia
ribociclib
ticolubant
mercaptopurine
lenzilumab
immunokinase
piposulfan
antileukemia
antiprotease
gilteritinib
forodesine
ofatumumab
sotrastaurin
ivosidenib
kalicludin
mubritinib
alemtuzumab
homoharringtonine
trilaciclib
olutasidenib
proprotease
pelitinib
roscovitine
boceprevir
azaguanine
stefin
tucatinib
tagitinine
antiprostaglandin
chloromercuribenzoic acid
proteinase
glecaprevir
nonleukemic
506U78
phenylmethylsulfonylfluoride
proteotoxin
telaprevir
caspase
leukemogenicity
multicorn
alveolin
paludrine
cytarabine
phenylmethanesulfonylfluoride
HER-2
ipatasertib
ubistatin
livin
succinylproteome
chymostatin
proteoclastic
leukemic
parafibromin
belumosudil
proteolytical
tigatuzumab
preprosomatostatin
nonleukemogenic
immunoproteome
aprotinin
thymoglobulin
paullone
anamorsin
fludarabine